#4180 on the rich list of 14,644 insiders
Ying Du
Chairperson & CEO at Zai Lab. Based in Cambridge, Massachusetts.
$26.5M
in disclosed stock, −$489K (−1.81%) today
Live prices, last trade 3:15 PM ET
- Rank
- 4180th of 14,644
- Companies held
- 1
- Largest holding
- ZLAB, 100.0% of total
- Latest SEC filing
- Jul 2, 2026
What the $26.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Zai Lab ZLAB American Depositary Shares | Directly | 1,221,401 | $21.71 | $26.5M | 100.0% | Form 4, Jul 2, 2026 |
Share counts are the amounts Ying Du reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Sold | ZLAB | 7,026 | $18.53 | $130K | View |
| Jun 26, 2026 | Sold | ZLAB | 24,543 | $17.46 | $429K | View |
| May 18, 2026 | Sold | ZLAB | 50,000 | $19.00 | $950K | View |
| May 15, 2026 | Sold | ZLAB | 50,000 | $20.74 | $1.0M | View |
| May 14, 2026 | Sold | ZLAB | 50,000 | $20.09 | $1.0M | View |
| May 13, 2026 | Sold | ZLAB | 16,231 | $19.44 | $316K | View |
| May 13, 2026 | Sold | ZLAB | 33,769 | $20.22 | $683K | View |
| Apr 6, 2026 | Sold | ZLAB | 2,653 | $20.45 | $54K | View |
| Apr 2, 2026 | Sold | ZLAB | 5,576 | $20.39 | $114K | View |
| Mar 11, 2026 | Sold | ZLAB | 1,067 | $19.08 | $20K | View |
| Mar 9, 2026 | Sold | ZLAB | 50,000 | $19.03 | $952K | View |
| Mar 6, 2026 | Sold | ZLAB | 50,000 | $19.42 | $971K | View |
| Mar 5, 2026 | Sold | ZLAB | 50,000 | $19.22 | $961K | View |
| Mar 4, 2026 | Sold | ZLAB | 14,290 | $18.78 | $268K | View |
| Mar 4, 2026 | Sold | ZLAB | 35,710 | $19.32 | $690K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4177 | Giovanni Caforio Executive Chair of the Board, Bristol-Myers Squibb. Portage, MI | $26.5M |
| 4178 | Luc Seraphin President and CEO, Rambus. San Jose, CA | $26.5M |
| 4179 | Jason M. Adler Director, Cronos Group | $26.5M |
| 4180 | Ying Du Chairperson & CEO, Zai Lab. Cambridge, MA | $26.5M |
| 4181 | Randy L. Newman Director, Alerus Financial. Grand Forks, ND | $26.5M |
| 4182 | Michael Cordonnier CEO, President, Carlsmed. Carlsbad, CA | $26.5M |
| 4183 | Marco Mariotti Pres. Eastern Europe Region, Philip Morris International. New York, NY | $26.5M |
Other Zai Lab insiders
All ZLAB insiders- Peter Wirth$9.0MDirector. #9486 overall
- Leon O. Moulder Jr.$2.1MDirector. #1167 overall
- Michel Vounatsos$1.6MDirector. #5132 overall
- Alan B. Sandler$629KHead of Global Dev., Oncology. #9497 overall
Questions
How much stock does Ying Du own?
Ying Du holds $26,516,616 in listed stock based on SEC filings and current prices, mostly Zai Lab (ZLAB). That ranks 4180th on the Stock Rich List.
Is this Ying Du's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Ying Du last buy or sell stock?
The most recent open-market trade on file is a sale of 7,026 ZLAB shares on Jun 30, 2026 at $18.53.